Status: current, Defined. Date: 31-Dec 2012. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2473671000168117 | Reyataz (atazanavir 300 mg) capsule, 30 capsules, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2473681000168119 | Reyataz 300 mg capsule, 30, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Reyataz 300 mg capsule, 30, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Reyataz 300 mg capsule, 30, bottle | Is a | Reyataz 300 mg capsule, 30 | true | Inferred relationship | Some | ||
| Reyataz 300 mg capsule, 30, bottle | has container type | bottle | true | Inferred relationship | Some | ||
| Reyataz 300 mg capsule, 30, bottle | has TP | Reyataz | true | Inferred relationship | Some | ||
| Reyataz 300 mg capsule, 30, bottle | has TPUU | Reyataz 300 mg capsule | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR